These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8452575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum.
    Burruss JB, Farmer ER, Callen JP.
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):720-4. PubMed ID: 8912567
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A case of refractory adult dermatomyositis.
    Whallett AJ, Gillott TJ, Klocke R, Coppock JS.
    Br J Rheumatol; 1998 May; 37(5):544-5. PubMed ID: 9651083
    [No Abstract] [Full Text] [Related]

  • 6. [Experiences in the treatment of dermatomyositis with immunosuppressiva].
    Stögmann W.
    Padiatr Padol; 1972 May; 7(3):305-10. PubMed ID: 5056406
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH, Hausner-Sypek DL, Weinblatt ME.
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
    Ramanan AV, Campbell-Webster N, Ota S, Parker S, Tran D, Tyrrell PN, Cameron B, Spiegel L, Schneider R, Laxer RM, Silverman ED, Feldman BM.
    Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
    [Abstract] [Full Text] [Related]

  • 10. Non-corticosteroid treatment for nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD002290. PubMed ID: 18254005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive treatment of collagen diseases].
    Cruchaud A.
    Ther Umsch; 1969 Dec 23; 26(12):697-702. PubMed ID: 5386688
    [No Abstract] [Full Text] [Related]

  • 13. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH, Hoogendijk JE, Lecky B, Winer JB.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD003643. PubMed ID: 16034905
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
    Oddis CV, Medsger TA.
    J Rheumatol; 1988 Jul 20; 15(5):807-11. PubMed ID: 3172094
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy.
    Metzger AL, Bohan A, Goldberg LS, Bluestone R, Pearson CM.
    Ann Intern Med; 1974 Aug 20; 81(2):182-9. PubMed ID: 4843574
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.